Laurus Labs profit and loss

Latest FY26

Revenue: ₹6,813cr+22.7% on FY25
EBITDA: ₹1,778cr+68.5% on FY25
Net profit: ₹890cr+148.4% on FY25
EPS: ₹16.47+147.7% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	7,823	6,813	5,554	5,041	6,041	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	39.8	55.0	75.1	26.3	6.0
	7,862	6,868	5,629	5,067	6,047
	3,205	2,794	2,429	2,422	2,597
	183	173	105	111	156
	−421	−271	−55.9	−101	22.0
	990	895	720	640	581
	166	171	216	183	165
	494	480	430	385	324
	1,485	1,444	1,301	1,191	1,093
	6,101	5,686	5,145	4,831	4,938
	2,381	1,778	1,055	778	1,592
	1,887	1,298	625	393	1,268
Profit
	1,761	1,182	484	236	1,109
	1,761	1,182	484	236	1,109
	447	298	157	93.1	290
	−20.1	−5.5	−27.0	−25.0	22.5
	427	292	130	68.2	312
	−1.5	0.3	3.9	−5.9	−3.2
	1,332	890	358	162	793
	1,334	890	354	168	797
	−4.1	−5.9	−3.7	−2.9	−5.6
	1,328	884	355	159	788
	1,340	889	358	161	790
	−7.7	1.4	0.0	1.7	3.3
Per share
	₹24.82	₹16.47	₹6.65	₹2.98	₹14.69
	₹24.78	₹16.45	₹6.64	₹2.97	₹14.64
Other comprehensive income — detail
	−4.1	−5.9	−3.7	—	—
	−1.6	2.8	−1.4	−1.2	0.8
	−1.2	0.0	0.0	—	—
	—	—	—	−0.3	0.2
	−3.7	−8.7	−2.3	−2.0	−6.2
	1,336	883	355	158	785
	−7.7	1.3	0.0	1.7	3.3
Per share — as-filed variants
	₹24.82	₹16.47	₹6.65	₹2.98	₹14.69
	₹24.78	₹16.45	₹6.64	₹2.97	₹14.64
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	4,856	4,117	3,076	2,608	3,266
	62.1%	60.4%	55.4%	51.7%	54.1%
Adjusted (ex-exceptional items) — derived
	1,761	1,182	484	236	1,109
	1,332	890	358	162	793
	₹24.82	₹16.47	₹6.65	₹2.98	₹14.69

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

LAURUSLABS₹2,181.90

Laurus Labs Ltd.

· Pharma & Health

Annual Quarterly₹ CrorePeersDIVISLAB GLAND MANKIND BIOCON ALKEM LUPIN FORTIS GLENMARKMcap ₹1.18L Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Revenue from Operations	6,040.6	5,040.8	5,554.0	6,812.9	7,822.5
Other Income	6.0	26.3	75.1	55.0	39.8
Total Income	6,046.6	5,067.2	5,629.1	6,867.9	7,862.3
Expenses
+ Cost of Materials Consumed	2,596.6	2,422.4	2,428.6	2,794.3	3,204.6
+ Purchases of Stock-in-Trade	155.7	110.9	105.4	172.6	183.5
+ Changes in Inventories	22.0	-100.9	-55.9	-271.4	-421.4
+ Employee Benefit Expense	580.6	639.9	719.5	895.5	989.5
+ Finance Costs	165.2	182.9	216.0	170.7	165.6
+ Depreciation & Amortisation	324.1	384.6	430.1	480.1	494.0
+ Other Expenses	1,093.4	1,191.0	1,301.2	1,444.3	1,485.4
Total Expenses	4,937.6	4,830.8	5,144.8	5,686.0	6,101.2
EBITDA	1,592.2	777.5	1,055.3	1,777.7	2,380.9
EBIT	1,268.1	392.9	625.2	1,297.7	1,886.9
Profit
PBT before Exceptional Items	1,108.9	236.4	484.3	1,181.9	1,761.1
Pretax Income	1,108.9	236.4	484.3	1,181.9	1,761.1
+ Current Tax	289.8	93.1	156.9	297.5	447.4
+ Deferred Tax	22.5	-25.0	-27.0	-5.5	-20.1
Tax Expense	312.3	68.2	129.9	292.0	427.4
+ Share of Associates & JVs	-3.2	-5.9	3.9	0.3	-1.5
Net Income	793.4	162.3	358.3	890.1	1,332.2
+ Net Income — Continuing Ops	796.6	168.2	354.4	889.9	1,333.8
+ Other Comprehensive Income	-5.6	-2.9	-3.7	-5.9	-4.1
Total Comprehensive Income	787.8	159.4	354.7	884.2	1,328.2
Net Income to Common	790.1	160.6	358.3	888.8	1,339.9
Minority Interest	3.3	1.7	0.0	1.4	-7.7
Per Share
Basic EPS	14.69	2.98	6.65	16.47	24.82
Diluted EPS	14.64	2.97	6.64	16.45	24.78
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-3.7	-5.9	-4.1
+ Items NOT to be Reclassified to P&L	0.8	-1.2	-1.4	2.8	-1.6
+ Tax on Items NOT to be Reclassified	—	—	0.0	0.0	-1.2
+ Tax on Items NOT to be Reclassified — alt tag	0.2	-0.3	—	—	—
+ Items to be Reclassified to P&L	-6.2	-2.0	-2.3	-8.7	-3.7
Comprehensive Income — Owners of Parent	784.5	157.7	354.7	882.9	1,335.8
Comprehensive Income — Non-controlling Interests	3.3	1.7	0.0	1.3	-7.7
Per Share — as-filed variants
Basic EPS — Continuing Operations	14.69	2.98	6.65	16.47	24.82
Diluted EPS — Continuing Operations	14.64	2.97	6.64	16.45	24.78
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	3,266.2	2,608.4	3,076.0	4,117.4	4,855.8
Gross Margin %	54.07	51.75	55.38	60.44	62.07
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	1,108.9	236.4	484.3	1,181.9	1,761.1
Net Income Adj (tax-effected)	793.4	162.3	358.3	890.1	1,332.2
EPS Adj	14.69	2.98	6.65	16.47	24.82
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	2.00	2.00	2.00	2.00	2.00
Paid Up Equity Capital	107.7	107.8	107.9	108.0	108.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.